HOME AND AMBULATORY BLOOD PRESSURE MONITORING

Slides:



Advertisements
Similar presentations
Treatment of hypertension: What are the new standards of care?
Advertisements

Blood Pressure Assessment and Stroke 2009 Preventing Strokes One At a Time.
Preventing Strokes One at a Time Acute Interventions and Management 2009.
JNC 8 Guidelines….
EVERYTHING YOU WANTED TO KNOW ABOUT IT BUT DID NOT DARE TO ASK ABPM (Ambulatory Blood Pressure Monitoring)
Hypertension. Hypertension or high blood pressure is a chronic medical condition in which the blood pressure in the arteries is elevated. This requires.
National Institute for Health and Clinical Excellence.
Update on hypertension - diagnosis, monitoring and guideline treatment targets Prof. Richard McManus, Birmingham, United Kingdom.
CME Program for Family Physicians Ambulatory BP Monitoring Brian Gore, MD CCFP Dip Epid. CME Program for Family Physicians Ambulatory BP Monitoring Brian.
Diagnosis and initial management of hypertension in primary care
© Continuing Medical Implementation …...bridging the care gap Blood Pressure Measurement How can anything so simple be so complex?
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Canadian Diabetes Association Clinical Practice Guidelines Treatment of Hypertension Chapter 25 Richard E. Gilbert, Doreen Rabi, Pierre LaRochelle, Lawrence.
© Continuing Medical Implementation …...bridging the care gap Blood Pressure Measurement 2005 How can anything so simple be so complex?
Blood Pressure Monitoring
MT Najafi Oct 2014 Introduction  Self-monitoring of blood pressure by patients at home (home blood pressure monitoring (HBPM)) is being increasingly.
Use of ABPM to diagnose hypertension
In the Name of God In the Name of God Overview of Hypertension Mahboob Lessan Pezeshki MD Tehran University of Medical Sciences Aban 1392.
A guide for healthcare professionals Measuring Blood Pressure at Home Michigan Department of Community Health Heart Disease and Stroke Prevention Unit.
Office and Home Blood Pressure Assessment Hypertension Diagnosis and Follow up 2011 Canadian Hypertension Education Program Recommendations.
Implementing NICE guidance
Assessment, Targets, Thresholds and Treatment Bryan Williams NICE clinical guideline 127.
HYPERTENSION The Alabama Department of Public Health’s Hypertension Program.
CME Program for Family Physicians Ambulatory BP Monitoring Brian Gore, MD CCFP Dip Epid. Part II ABPM.
DECREASING SLEEP-TIME BLOOD PRESSURE DETERMINED BY AMBULATORY MONITORING REDUCES CARDIOVASCULAR RISK Ramón C. Hermida, PhD; Diana E. Ayala, MD, MPH, PhD;
Improving the Quality of Physical Health Checks
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
Vascular Risk Reduction: Identifying Vascular Risk.
Journal Club ADAM WILCOX, PHARMD 1/22/14. Patient Case  DB, 70 yo M  Overall ABPM summary  Avg. BP = 116/62  Daytime = 120/63  Nighttime = 103/58.
Definitions and classification of office blood pressure levels (mmHg) Modified by ESC Guidelines 2013 CARDIOcheckAPP.
10/5/2015. Hypertension GuidelinesDate JNC JNC JNC NICE Guidelines 2011 ESC / ESH Hypertension Guidelines ESC Guideline2007.
Blood pressure control in primary health care WORKSHOP
Hypertension NICE CG127 August Hypertension is not a disease it is a risk factor for cardiovasuclar disease (CVD)-it is a modifiable risk factor.
Hypertension: Blood Pressure Measurement and the new NICE guideline Prof Richard McManus BHS Annual Meeting Cambridge 2011 NICE clinical guideline 127.
Hypertension Dr Nidhi Bhargava 8/10/13. Why Treat Increased risk of cardiovascular death and mortality Increased systolic, diastolic and pulse pressures.
Pharmacist-Physician Collaborative Medication Therapy Management Services (MTMS) PI: Jan Hirsch, RPh, PhD Carol M. Mangione, MD, MSPH Barbara A. Levey.
Hypertension Family Medicine Specialist CME October 15-17, 2012 Pakse.
PHARMACOTHERAPY OF HYPERTENSION Based on New Guidelines Fariborz Nikaeen; MD Interventional cardiologist 2 november 2015.
Section I. Accurate Measurement of Blood Pressure
WHAT IS HYPERTENSION? Liz Corrigan Vascular Programme Advisor Office of Public Health Dudley MBC.
A Controlled Trial of Renal Denervation for Resistant Hypertension
2015 Canadian Hypertension Education Program Recommendations
Section VII. Home BP Measurement 2015 Canadian Hypertension Education Program Recommendations.
2007 Hypertension as a Public Health Risk January, 2007.
Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements Reference:
Measuring Blood Pressure. Diagnostic Criteria for HTN Two or more separate occasions – BP > 140/90 –Average of Seated Standing for > 2 min Seated with.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Getting Blood Pressure To Goal: a Pressurized Process Grant M. Greenberg M.D., M.A., M.S.H.A.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Screening System for Hypertension and Diabetes at Primary Care Level
Dr John Cox Diabetes in Primary Care Conference Cork
Clinical Management of primary hypertension
Nephrology Journal Club The SPRINT Trial Parker Gregg
Blood Pressure Hypertension Orthostatics
Diagnosis and initial management of hypertension in primary care
Paul A. Sobotka, MD Professor of Medicine/Cardiology
From ESH 2016 | POS 3C: Chiara Lorenzi, MD
A.M. Thompson, T.G. Pickering  Kidney International 
FDA Pathway to Approval: Clinical Requirements for Renal Denervation
Eoin O’Brien, DSc, MD, Eamon Dolan, MD, FRCPI  Clinical Therapeutics 
From ESH 2016 | POS 7D: Jan Rosa, MD
What’s New in the 2013 ESC/ESH Hypertension Guideline
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
Progress and Promise in RAAS Blockade
Section VIII. Ambulatory BP Measurement
Managing Hard-To-Treat Hypertension: What Every Physician Should Know
Primary Hypertension Max C. Reif, M.D.
Appendix 1: methods used for guideline development
Hypertension Implementing NICE guidance 2 nd Edition March 2013 NICE clinical guideline 127.
Presentation transcript:

HOME AND AMBULATORY BLOOD PRESSURE MONITORING Home and ambulatory blood pressure monitoring are tools which are available to us now which we should undoubtedly be making use of. These modalities have really come of age. It has been said, and there is some truth in it, that most of the big outcome hypertension medication trials have been based on office blood pressure measurements. However, there is now ample evidence correlating ABPM and home BPM with cardiovascular outcome, and in fact they are both superior to office BP in predicting outcome

Both these modalities are useful because they get us a look at the patient’s blood pressure away from the office/clinic environment and also give us insight in to the 24-hour BP profile. You know that sleeping blood pressures should be the lowest, and the highest blood pressures are usually in the early morning – office/clinic blood pressures give us no information about these things. There is also potentially important information to be obtained with regard to timing of blood pressure medications;- most antihypertensives are supposed to last for 24 hours but many actually don’t. If the meducation is taken at 8am and you are seeing the patient at 11am their BP may be fine (3 hours post-dose) but you may be missing a potentually hazardous “early morning surge”.

Uses of ABPM and Home BPM Diagnosis of Hypertension Diagnosis of White Coat Hypertension Diagnosis of Masked Hypertension Assessment of prognostically important asleep and early morning blood pressures Monitoring efficacy of treatment

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement Elevated Out of the Office BP measurement Elevated Random Office BP Measurement Hypertension Visit 1 BP Measurement, History and Physical examination Hypertensive Urgency / Emergency Diagnosis of HTN Diagnostic tests ordering at visit 1 or 2 Yes BP ≥ 140/90 mmHg and Target organ damage or Diabetes or Chronic Kidney Disease or BP ≥ 180/110? Hypertension Visit 2 within 1 month BP: 140-179 / 90-109 No

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement BP: 140-179 / 90-109 ABPM (If available) Clinic BPM HBPM Yes Hypertension Visit 2 Target Organ Damage or Diabetes or Chronic Kidney Disease or BP ≥ 180/110? Hypertension Visit 1 BP Measurement, History and Physical examination Hypertensive Urgency / Emergency Diagnosis of HTN No

Diagnostic algorithm for high Blood Pressure including Office, ABPM and Home Blood Pressure Measurement BP: 140-179 / 90-109 ABPM (If available) Clinic BP HBPM ≥ 135 SBP or ≥ DBP 85 < 135/85 Diagnosis of HTN Continue to follow-up or Diagnosis of HTN Hypertension visit 3 ≥ 160 SBP or ≥ 100 DBP ≥ 140 SBP or ≥ 90 DBP < 140 / 90 Continue to follow-up < 160 / 100 Hypertension visit 4-5 ABPM or HBPM or Diagnosis of HTN Awake BP ≥ 135 SBP or ≥ 85 DBP Or 24-hour ≥ 130 SBP or ≥ 80 DBP < 135/85 and 24-hour < 130/80 Continue to follow-up

“Normal” Values Office BP < 140 / 90 (< 130/80 for DM, CKD, TOD) ABPM awake average < 135/85 (125/75 for DM, CKD, TOD) ABPM asleep average < 120/70 Home BPM average < 135/85 (125/75 for DM, CKD, TOD)

The concept of masked hypertension 140 True hypertensive Masked HTN Home or daytime ABPM SBP mmHg 135 135 True Normotensive White Coat HTN 140 Office SBP mmHg From Pickering, Hypertension 1992

The prognosis of masked hypertension Prevalence of masked hypertension is approximately 10% in the general population (prevalence is higher in diabetic patients). J Hypertension 2007;25:2193-98

Threshold for Initiation of Treatment and Target Values Condition Initiation SBP / DBP mmHg Diastolic ± systolic hypertension  140/90 Isolated systolic hypertension SBP >160 Home BP measurement (no diabetes, renal disease or proteinuria) ( 135/85) Diabetes or chronic kidney disease  130/80 Target SBP / DBP mmHg <140/90 <140 <135/85 <130/80 The systolic blood pressure target are highlighted to indicate systolic blood pressure control is the major clinical issue currently for most patients

Home measurement of blood pressure Home BP measurement should be encouraged to increase patient involvement in care Which patients? For the diagnosis of hypertension Suspected non adherence White coat hypertension or effect Masked hypertension Average BP equal to or over 135/85 mmHg should be considered elevated

Benefits of Home Blood Pressure Monitoring Rapid confirmation of the diagnosis of hypertension Better prediction of cardiovascular prognosis Diagnosis of white coat and masked hypertension Reduced medication use in white coat effect Improved adherence to drug therapy Better blood pressure

Not all patients are suited to home measurement Undue anxiety in response to high blood pressure readings Physical or mental disability prevents accurate technique or recording Arm not suited to blood pressure cuff (e.g. conical shaped arm) Irregular pulse or arrhythmias prevent accurate readings Lack of interest The vast majority of patients can be trained to measure blood pressure

Suggested Protocol for Home Measurement of Blood Pressure for the diagnosis of hypertension Home blood pressure values should be based on: duplicate measures, morning and evening, for an initial 7-day period. Singular and first day home BP values should not be considered. Daytime average BP equal to or over 135/85 mmHg should be considered elevated

Home Measurement of BP: Patient Education How to? Use devices: appropriate for the individual appropriate cuff size validated device Adequate patient training in: measuring their BP interpreting these readings Regular verification measuring techniques Values > 135 / 85 mmHg should be considered elevated Home measurement can help to improve patient adherence

Suggested Protocol for Home Measurement of Blood Pressure How? Home blood pressure values for assessing white coat hypertension or sustained hypertension should be based on: Duplicate measures, Morning and evening, For an initial 7-day period. Single readings and First day home BP values should not be considered. For patients treated for hypertension Morning measurement should be done before medication taking

Home Measurement of BP: Patient Education Assist patients select a model with the correct size of cuff Measure and record the patients mid arm circumference so they can match it to cuff size Recommend devices validated by British Hypertension Society Ask patients to carefully follow the instructions with device and to record only those blood pressure readings where they have followed recommended procedure Advise patients that average readings equal to or over 135/85 mmHg are high a lower threshold is appropriate for those with diabetes or chronic kidney disease Values equal to or over 135 / 85 mmHg should be considered elevated for those without diabetes or chronic kidney disease Home measurement can help to improve patient adherence

Which monitor to recommend to patients? British Hypertension Society maintains an updated list of validated home BP monitors http://www.bhsoc.org/bp_monitors/automatic.stm (or Google “British Hypertension Society” and click on “Blood pressure Monitors”)

Suggested use of ABPM AND Home BPM in the Management of Hypertension Office BP > 140/90 mmHg in low risk patients (with no target-organ disease) Home-monitored blood pressure <135/85mmHg Home-monitored blood pressure equals or over 135/85mmHg Perform ABPM White coat hypertension and ‘non dipping’ is not reproduced in a repeat monitor 30-40% of the time Mean awake BP Less than 135/85 mmHg Mean awake BP equals or over 135/85 mmHg Follow-up with periodic home-BP measurement and or repeated ABPM every 1-2yr. Initiate antihypertensive therapy ABPM: Ambulatory Blood Pressure Monitoring BP: Blood Pressure Adapted from White W, NEJM 348:24, June 12, 2003

Special Indications for ABPM Suspect white coat hypertension 20% of individuals with office hypertension have normal profile on ABPM These people do not generally require drug therapy (although their risk is slightly higher than true normotensives) They have a higher risk of progression to establised hypertension and need to be followed long-term (may need eg annual ABPM)

(2) Masked Hypertension Office BP < 140/90 (or 130/80 in DM or CKD) with: awake average BP on ABPM >= 135/85 (125/75 in DM or CKD) or or 24 hour average BP on ABPM >= 130/80 (120/70 in DM or CKD) Suspect where target organ damage with normal office blood pressures Untreated associated with adverse prognosis .

(3) Assess Nocturnal Dip and Morning Surge Average asleep blood pressure should be at least 10% lower than average awake blood pressure (“nocturnal dip”) “Non-dipper” status associated with adverse cardiovascular prognosis (common is states of sympathetic overactivity eg diabetes and CKD) Highest blood pressures usually in the early morning (6-10am) – highest risk time for MI and stroke. Exaggerated surge (> 160/100) is a significant risk factor even when average blood pressure adequately controlled. (NB many “24-hour” antihypertensive meds are wearing off at the time of highest risk) Both non-dipping and morning surge can be addressed by apropriately timed adjustment to meds use drugs know to have long ½ lives evening or bedtime dosing or 1 or more drugs (or even 3am if getting up to PU at that time) .

(4) Assess Efficacy of Treatment Some treated hypertensives have an office “white coat” effect and appear to be resistant to increasing therapy - these individuals may need serial ABPM to monitor the effect of therapy. Home BP monitoring is also useful in these individuals

CONCLUSION: Ambulatory and Home Blood Pressure Monitoring are now an integral (evidence-based) part of hypertension management and should be widely used.